A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/00 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/17 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2361256
The invention relates to a method for treating inflammatory demyelinating diseases. The method comprises administering to a subject in need an effective amount of an antagonist of CCR1 function. In a preferred embodiment, the invention provides a method for treating multiple sclerosis.
L'invention se rapporte à une méthode de traitement des troubles inflammatoires démyélinisants. Cette méthode consiste à administrer à un sujet nécessitant un tel traitement une quantité efficace d'un antagoniste de la fonction CCR1. Dans une réalisation préférée, l'invention se rapporte à une méthode de traitement de la sclérose en plaques.
Hancock Wayne W.
Rottman James B.
Millennium Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Method of treating demyelinating inflammatory disease using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating demyelinating inflammatory disease using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating demyelinating inflammatory disease using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1708627